Search PubMed⌕ Search

Biomedical subjects

O Olsson

Publications and source records attributed to O Olsson.

At least 73 records · Page 4Linked to original sources

[Kinetic study of antitumor lymphocyte cytotoxicity in rats bearing progressive or regressive syngeneic colonic tumors].

In order to perform a kinetic study of the antitumor lymphocyte-mediated cytotoxicity in syngeneic BDIX rats bearing progressive (TRb) or regressive (TSb) colonic tumors, the 51Cr release assay was adapted to this experimental model. Two groups of 72 rats were inoculated with TRb or TSb cells. Results failed to show any clear and univocal evolution of lymphocyte cytotoxicities against TRb or TSb cells. On the other hand these cytotoxicities were roughly at the same level than natural cytotoxicity (normal rats), and were always higher against TSb than TRb cells.

Adenocarcinoma↗

Nucleotide sequence of the papA gene encoding the Pap pilus subunit of human uropathogenic Escherichia coli.

The papA gene of the uropathogenic strain Escherichia coli J96, coding for the Pap pili subunit, was subjected to DNA sequencing, and found to code for an 185-amino acid-long polypeptide with a 22-amino acid-long signal peptide. Here we present the primary sequence, the hydrophilicity profile, and the predicted polypeptide secondary structure of the Pap pili subunit.

Amino Acid Sequence↗

[Immunoenzymatic detection of circulating antitumor antibodies in the rat: development of a quantitative technic and its use in rats bearing grafted colonic tumors].

In order to study the humoral immune response of rats against a colonic tumor, we developed an immuno-enzymatic technique for quantitating specific anti-tumoral antibodies. This technique which uses a monolayer of intact cancer cells as antigen produces objective and reproducible results. Applied to eleven rats carrying grafted colon carcinomas, it allowed the characterization of three different types of evolution of the concentration of circulating antibodies.

Animals↗

ampC beta-lactamase hyperproduction in Escherichia coli: natural ampicillin resistance generated by horizontal chromosomal DNA transfer from Shigella.

Six ampicillin-resistant clinical isolates of Escherichia coli that hyperproduced the chromosomal ampC beta-lactamase were studied. By DNA sequence analysis, we found that five of them were identical over an entire 449-base-pair sequence and carried a novel strong ampC promoter [Olsson, O., Bergström, S. & Normark, S. (1982) EMBO J. 1, 1411-1416]. Except for one base pair this sequence was identical to that of a low beta-lactamase-producing clinical isolate of Shigella sonnei. Spontaneous one-step mutants of S. sonnei that overproduced the ampC beta-lactamase by 45-fold were characterized and found to be mutated at the single base that distinguishes S. sonnei from the five E. coli hyperproducers. The most likely explanation for this result is that chromosomal DNA was transferred in vivo from Shigella to E. coli across the species barrier.

Ampicillin↗

Comparison of the overlapping frd and ampC operons of Escherichia coli with the corresponding DNA sequences in other gram-negative bacteria.

Specific DNA probes from Escherichia coli K-12 were used to analyze the sequence divergence of the frd and ampC operons in various species of gram-negative bacteria. These operons code for the fumarate reductase complex and the chromosomal beta-lactamase, respectively. We demonstrate that the two operons show the same general pattern of divergence, although the frd operon is considerably more conserved than is the ampC operon. The major exception is Salmonella typhimurium LT2, which shows a strong homology to the E. coli frd probe but none to the E. coli ampC probe. The operons from Citrobacter freundii and Shigella sonnei were cloned and characterized by physical mapping, Southern hybridization, and protein synthesis in minicells. In S. sonnei, as in E. coli K-12, the frd and ampC operons overlap (T. Grundström and B. Jaurin, Proc. Natl. Acad. Sci. U.S.A. 79:1111-1115, 1982). Only minor discrepancies between the two operons were found over the entire frd-ampC region. In C. freundii, the ampC and frd operons do not overlap, being separated by about 1,100 base pairs. Presumably the inducible property of the C. freundii chromosomal beta-lactamase is encoded by this 1,100-base-pair DNA segment.

Base Sequence↗

Overlapping genes.

Explore the source record for details and available documents.

Base Sequence↗

Identification of a novel ampC beta-lactamase promoter in a clinical isolate of Escherichia coli.

A clinical strain of Escherichia coli, C16, that overproduces the ampC beta-lactamase was isolated. A 203-bp DNA segment from this strain, including the promoter and attenuator region of the ampC structural gene, was sequenced. A comparison with the corresponding sequence of E. coli K12 revealed four base pair differences between the ampC segments from these strains. DNA sequence data and in vitro transcription indicated that the ampC promoter in the clinical isolate was displaced 5 bp upstream of the promotor defined in the E. coli K12 strain. Like the ampC gene of E. coli K12, the ampC gene from the clinical isolate was metabolically regulated. However, the increase in the specific amount of beta-lactamase relative to the increase in specific growth rate was much higher in the clinical isolate. These data imply that the growth rate-dependent anti-termination acting on the ampC attenuator in vivo is more pronounced in the clinical E. coli isolate than in E. coli K12. A possible molecular mechanism for this is discussed.

Base Sequence↗

Common evolutionary origin of chromosomal beta-lactamase genes in enterobacteria.

A 32P-labeled fragment of DNA, encoding the major part of the chromosomal ampC beta-lactamase gene of Escherichia coli K-12, was used as a hybridization probe for homologous DNA sequences in colonies of Neisseria gonorrhoeae, Pseudomonas aeruginosa, and different enterobacterial species. The ampC probe detected the presence of homologous DNA sequences in clinical isolates of E. coli, Shigella flexneri, Shigella sonnei, Klebsiella pneumoniae, Salmonella typhimurium, Serratia marcescens, and P. aeruginosa. No hybridization was found with N. gonorrhoeae colonies. In Southern blotting experiments the ampC probe hybridized to chromosomal DNA fragments of the same size in all enterobacterial species tested. However, the degree of hybridization differed with DNA from different species. DNA from the Shigella species strongly hybridized to the ampC probe. Furthermore, antibodies raised against purified E. coli K-12 ampC beta-lactamase precipitated beta-lactamases from the Shigella species, suggesting extensive sequence similarities between the ampC genes of these genera. The production of chromosomal beta-lactamase in S. sonnei increased with increasing growth rate similar to E. coli K-12. This growth rate response was abolished in two beta-lactamase-hyperproducing S. sonnei mutants, which thus seem similar to E. coli K-12 attenuator mutants. We propose that both the structure and regulation of the chromosomal beta-lactamase genes are very similar in E. coli and in S. sonnei.

Base Sequence↗

Tumoricidal effect of macrophages exposed to adriamycin in vivo or in vitro.

Peritoneal macrophages from BD IX rats collected 24 hr after an i.p. injection of ADriamycin (10 mg/kg) were cytotoxic to syngeneic cancer cells in culture. In contrast, incubation in vitro in Adriamycin solutions did not evoke tumoricidal activity in peritoneal macrophages, whatever the incubation time (from 1 to 24 hr) and the Adriamycin concentration (from 1 ng to 100 micrograms/ml). Macrophages incubated with Adriamycin in vitro accumulated the drug in their nuclei, whereas macrophages from animals receiving Adriamycin in vivo accumulated it is cytoplasmic vacuoles. Early observation of peritoneal cells after in vivo exposure to Adriamycin shows that Adriamycin is concentrated in mast cell granules which are released and then phagocytosed by peritoneal macrophages. Mast cells exposed to Adriamycin in vitro can induce macrophages to become cytotoxic. These facts explain the difference between macrophages exposed to Adriamycin in vivo and in vitro. Adriamycin fluorescence appears in nuclei of cancer cells incubated with in vivo-labeled macrophages, suggesting that macrophages can directly transfer the drug into cancer cells and therefore play a role in the Adriamycin antitumor effect.

Animals↗

Heavy drug abuse in Sweden 1979 - a national case-finding study.

An investigation was carried out as a case-finding study to estimate the scale of heavy drug abuse in Sweden. Just over 8200 persons were reported as heavy drug abusers, 80% of these as injecting. For the majority of those reported more than one type of drug was indicated. There was concurrent abuse of alcohol by a majority of the heavy drug abusers. After correction of non-response with a modified capture-recapture technique and for erroneous classification, the scale of heavy drug abuse was estimated at 10000 - 14000 persons.

Adult↗

Effects of ethanol on the developing rat. I. Ethanol metabolism and effects on lactate, pyruvate, and glucose concentrations.

Ethanol, 27.1 mmol/kg, or saline, was administered to rats (n = 120) in classes weighing 25, 50, 100, 150, 200, and 250 g. The metabolic rate of ethanol (g/kg X min-1) was more than three times higher in adult animals than in new-born ones. The lactate to pyruvate ratio was unchanged in the lowest weight class, but increased in all the others. Using freeze-clamp technique to determine liver lactate to pyruvate ratio, the ratio was significantly higher in ethanol-treated rats in all weight classes. Ethanol induced a significant hypoglycemia in the lowest weight class but not in any other class. Thus the metabolic responses to ethanol were found to be different during various stages of development in the rat.

Age Factors↗

Effects of ethanol on the developing rat. II. Coordination as measured by the tilting-plane test.

Ethanol 27.1 mmol/kg body weight, was administered intraperitoneally to rats in the weight classes 25, 50, 100, 150, 200 and 250 g. Controls were given saline, the total number of animals used being 120. Blood ethanol concentration and performance on the tiling-plane test was determined before and up to six hours after administration. Total ethanol elimination was low in the smallest weight classes, increasing during adolescence. The three smallest weight classes showed no impairment of performance after ethanol, while the 150-250 g classes were significantly impaired during the time of maximum blood ethanol concentration.

Age Factors↗

[Effect of 15 antineoplastic drugs on colon carcinoma growing in vitro: a screening assay for cytotoxicity (author's transl)].

The cytotoxic effects of 15 drugs used in clinical oncology have been studied on rat colon cancer cells growing in vitro. A 50 per cent cytotoxic activity was obtained with molar concentration from 1.3 10(-8) to more than 4.10(-2), according to the drug. This cheap and quick assay could be useful for screening new drugs or new drug associations to be selected for clinical trials.

Animals↗